Inhibitor Therapeutics Statistics
Total Valuation
INTI has a market cap or net worth of 8.08 million. The enterprise value is 3.84 million.
| Market Cap | 8.08M |
| Enterprise Value | 3.84M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INTI has 172.32 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | 172.32M |
| Shares Outstanding | 172.32M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 37.62% |
| Owned by Institutions (%) | 1.74% |
| Float | 76.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.98 |
| P/TBV Ratio | 5.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.17 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 46.68, with a Debt / Equity ratio of 0.06.
| Current Ratio | 46.68 |
| Quick Ratio | 45.63 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -109.75% and return on invested capital (ROIC) is -73.19%.
| Return on Equity (ROE) | -109.75% |
| Return on Assets (ROA) | -36.15% |
| Return on Invested Capital (ROIC) | -73.19% |
| Return on Capital Employed (ROCE) | -80.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -547,889 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.09% in the last 52 weeks. The beta is -0.59, so INTI's price volatility has been lower than the market average.
| Beta (5Y) | -0.59 |
| 52-Week Price Change | -47.09% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 40.96 |
| Average Volume (20 Days) | 6,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.56M |
| Pretax Income | -3.29M |
| Net Income | -3.29M |
| EBITDA | n/a |
| EBIT | -3.56M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 4.32 million in cash and 84,348 in debt, giving a net cash position of 4.24 million or 0.02 per share.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 84,348 |
| Net Cash | 4.24M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.35M |
| Book Value Per Share | 0.01 |
| Working Capital | 4.33M |
Cash Flow
| Operating Cash Flow | -3.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | n/a |
| Earnings Yield | -40.67% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |